Literature DB >> 22454257

Efficient functional delivery of siRNA using mesoporous silica nanoparticles with ultralarge pores.

Hee-Kyung Na1, Mi-Hee Kim, Kihyun Park, Soo-Ryoon Ryoo, Kyung Eun Lee, Hyesung Jeon, Ryong Ryoo, Changbong Hyeon, Dal-Hee Min.   

Abstract

Among various nanoparticles, mesoporous silica nanoparticles (MSNs) have attracted extensive attention for developing efficient drug-delivery systems, mostly due to their high porosity and biocompatibility. However, due to the small pore size, generally below 5 nm in diameter, potential drugs that are loaded into the pore have been limited to small molecules. Herein, a small interfering RNA (siRNA) delivery strategy based on MSNs possessing pores with an average diameter of 23 nm is presented. The siRNA is regarded as a powerful gene therapeutic agent for treatment of a wide range of diseases by enabling post-transcriptional gene silencing, so-called RNA interference. Highly efficient, sequence-specific, and technically very simple target gene knockdown is demonstrated using MSNs with ultralarge pores of size 23 nm in vitro and in vivo without notable cytotoxicity.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22454257     DOI: 10.1002/smll.201200028

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  16 in total

Review 1.  The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal.

Authors:  Robert Roggers; Shrey Kanvinde; Suthida Boonsith; David Oupický
Journal:  AAPS PharmSciTech       Date:  2014-05-29       Impact factor: 3.246

Review 2.  Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention.

Authors:  Nicholas H Farina; Areg Zingiryan; Michael A Vrolijk; Scott D Perrapato; Steven Ades; Gary S Stein; Jane B Lian; Christopher C Landry
Journal:  J Cell Physiol       Date:  2018-04-16       Impact factor: 6.384

3.  Polycation-functionalized nanoporous silicon particles for gene silencing on breast cancer cells.

Authors:  Mingzhen Zhang; Rong Xu; Xiaojun Xia; Yong Yang; Jianhua Gu; Guoting Qin; Xuewu Liu; Mauro Ferrari; Haifa Shen
Journal:  Biomaterials       Date:  2013-10-05       Impact factor: 12.479

Review 4.  Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for Duchenne muscular dystrophy.

Authors:  Maria Sofia Falzarano; Chiara Passarelli; Alessandra Ferlini
Journal:  Nucleic Acid Ther       Date:  2014-02       Impact factor: 5.486

5.  Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.

Authors:  Neeraj Prabhakar; Jixi Zhang; Diti Desai; Eudald Casals; Tina Gulin-Sarfraz; Tuomas Näreoja; Jukka Westermarck; Jessica M Rosenholm
Journal:  Int J Nanomedicine       Date:  2016-12-08

Review 6.  Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer.

Authors:  Anna Watermann; Juergen Brieger
Journal:  Nanomaterials (Basel)       Date:  2017-07-22       Impact factor: 5.076

7.  Mesoporous Pt nanospheres with designed pore surface as highly active electrocatalyst.

Authors:  Bo Jiang; Cuiling Li; Victor Malgras; Masataka Imura; Satoshi Tominaka; Yusuke Yamauchi
Journal:  Chem Sci       Date:  2015-12-08       Impact factor: 9.825

Review 8.  Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer.

Authors:  Behrad Darvishi; Leila Farahmand; Keivan Majidzadeh-A
Journal:  Mol Ther Nucleic Acids       Date:  2017-03-29

9.  Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery.

Authors:  Jing Tu; Guangsheng Du; M Reza Nejadnik; Juha Mönkäre; Koen van der Maaden; Paul H H Bomans; Nico A J M Sommerdijk; Bram Slütter; Wim Jiskoot; Joke A Bouwstra; Alexander Kros
Journal:  Pharm Res       Date:  2017-05-23       Impact factor: 4.200

Review 10.  Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules.

Authors:  Rafael R Castillo; Daniel Lozano; María Vallet-Regí
Journal:  Pharmaceutics       Date:  2020-05-07       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.